Trump to sign order tying US drug prices to global rates
The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.
Recursion is streamlining its portfolio in the wake of its 2024 merger with Exscientia.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
3 reasons why biotechs preparing for launch need a compliant content foundation
Google-backed Isomorphic Labs raises $600m to advance AI drug discovery